Renovaro Inc. - Common Stock (RENB)
0.8456
-0.0481 (-5.38%)
Renovaro Inc. is a biotechnology company focused on the development of innovative therapies and solutions aimed at addressing unmet medical needs
The company specializes in advanced research and development in the field of regenerative medicine, utilizing cutting-edge technologies to create treatments that promote healing and recovery for patients suffering from various conditions. Through its commitment to scientific excellence and collaboration, Renovaro seeks to transform the healthcare landscape by bringing groundbreaking therapies from the lab to the clinic, ultimately improving patient outcomes and enhancing quality of life.

Wondering what's happening in Thursday's pre-market session? Find an overview in this article.
Via Chartmill · February 27, 2025

Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · February 26, 2025

Via Benzinga · January 6, 2025

Via Benzinga · October 17, 2024

Via Benzinga · October 4, 2024

Via Benzinga · October 4, 2024

Via Benzinga · October 4, 2024

Via Benzinga · October 3, 2024

Pre-market stock movers are worth diving into this morning as we check out all of the hottest news investors need to know about on Friday!
Via InvestorPlace · July 26, 2024

Via Benzinga · June 14, 2024

Via Benzinga · June 10, 2024

Via Benzinga · May 21, 2024

Renovaro Biosciences just reported results for the third quarter of 2024.
Via InvestorPlace · May 16, 2024

Renovaro Inc. (NASDAQRENB) Aims To Revolutionize Cancer Detection And Treatment Using Multi-Cancer Detection Model With Nvidia AI Chips For Leadership In Early Detection
Via News Direct · May 7, 2024

Via Benzinga · March 14, 2024

Shares of Bitdeer Technologies Group (NASDAQBTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin.
Via Benzinga · March 4, 2024

Hindenburg Research's short reports are legendary, and these three companies remain firmly within the activist short-seller's sights.
Via InvestorPlace · February 22, 2024

Renovaro Biosciences confronts Hindenburg's short report fallout, highlighting tech and business leaders joining the board. Despite false claims, the company asserts confidence.
Via Benzinga · February 14, 2024

Shares of IPG Photonics Corporation (NASDAQIPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance.
Via Benzinga · February 13, 2024

Via Benzinga · February 13, 2024

Renovaro Biosciences navigates challenges – from a controversial merger with GEDi Cube to allegations of securities law violations.
Via Benzinga · February 13, 2024

Gainers XORTX Therapeutics Inc. (NASDAQXRTX) shares jumped 60.2% to $0.5101 after jumping 34% on Thursday.
Via Benzinga · October 20, 2023